This inventor holds 75 USPTO granted patents and 7 published patent applications, plus 2 CIPO patents and 9 EPO patents, primarily in Peptide Engineering (CPC class 435 ). Top assignees: Medical Research Council, Cambridge Antibody Technology Limited, Bicycle Therapeutics Limited. Active years: 1993-2017. Nobel Prize laureate.
Inventors with similar research interests:
Location History:
- Trinity College, GB (2003)
- Chulmleigh, GB (2008)
- Cambridge, GB (1993 - 2017)
Company Filing History:
33 out of 259 
14 out of 28 
7 out of 8 
Years Active: 1993-2017
Areas of Expertise:
Title: Innovations of Gregory Paul Winter: A Pioneer in Multispecific Peptides
Introduction
Gregory Paul Winter, an esteemed inventor based in Cambridge, United Kingdom, has made significant contributions to the field of biochemistry and molecular biology. With an impressive portfolio of 75 patents, he is a recognized authority in developing novel therapeutic approaches, particularly in the area of multispecific peptides.
Latest Patents
One of Winter's latest patents focuses on multispecific peptides. This invention details a method for creating a multispecific peptide ligand that incorporates a polypeptide covalently linked to a molecular scaffold at three or more amino acid residues. Notably, this peptide is designed to bind to two or more separate targets, enhancing its therapeutic potential. The process involves several steps, including providing two repertoires of polypeptides, each equipped with reactive groups and loops containing sequences of amino acids. These loops are then conjugated to a molecular scaffold at multiple positions, forming a complex with improved binding capabilities.
Additionally, another significant innovation pertains to a complex comprising a phage particle that advances the understanding and application of peptides in scientific research and potential therapies.
Career Highlights
Throughout his illustrious career, Gregory Winter has worked with reputable institutions such as the Medical Research Council and Cambridge Antibody Technology Limited. His experience in these organizations has provided him with a robust platform to innovate and propel advancements in therapeutic technologies.
Collaborations
Winter has collaborated with notable colleagues, including Andrew David Griffiths and James David Marks. These partnerships signify the importance of teamwork in the pursuit of scientific breakthroughs and highlight the collaborative spirit that drives innovation in the biotechnology field.
Conclusion
Gregory Paul Winter stands as a significant figure in the realm of inventions and innovations, especially with his focus on multispecific peptides. His contributions through patents and collaborations exemplify the impact of scientific research on healthcare. By continually advancing biotechnological methods, Winter plays a critical role in shaping the future of therapeutic science.